Navigation Links
Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database

usefulness of the ProChart data to help them define the WWOX pathway and its role in tumor suppression.

While Cytogen's internal research and development initiatives focus on clinical-stage opportunities, the Company complements its internal programs with an active business development strategy, which includes capitalizing on the promising proprietary technology platforms, such as ProChart, previously developed through its AxCell BioSciences research-stage subsidiary.

In view of recent biological validation, as well as the progress of internal data mining efforts and external research collaborations, Cytogen is exploring strategic transactions for AxCell BioSciences and will be presenting today at the 9th Annual C21 BioVentures Conference (C21) taking place in Monterey, California.

About ProChart(TM)

ProChart is a proprietary, comprehensive, experimentally validated database of protein-protein signaling interactions mediated by WW, SH3, PDZ, and other modular domain families. Cytogen believes the application of ProChart may accelerate research and drug development by: (i) discovering novel signal transduction pathways and their relevant protein-protein interactions; (ii) rapidly identifying qualified drug targets; (iii) identifying potential unwanted side effects; (iv) identifying structure and activity relationship (SAR) information regarding domain and ligand interactions that can facilitate small molecule drug design; and (v) providing high throughput screening reagents (eg, cloned domains and ligands).

About Cytogen

Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and care of patients by building, developing, and commercializing a portfolio of oncology products. The Company's specialized sales force currently markets three therapeutic products and one diagnostic product to the U.S. oncology market. CAPHOSOL(R) is an advanced electrolyte solution for the treatment of oral mucositis and d
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
2. Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable Cytogenetics at EHA Meeting
3. New Data for Cytogens QUADRAMET Reported at Annual ASCO Meeting
4. Preclinical Data on Cytogens Technology to be Reported at the AACR Annual Meeting
5. New Clinical Data for Cytogens Quadramet and Prostacint to be Reported at Upcoming Major Medical Meetings
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
10. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
Post Your Comments:
(Date:5/23/2013)... 3SBio Inc. (NASDAQ: SSRX ... China -based biotechnology company focused on ... today that, at an extraordinary general meeting held ... favor of the proposal to authorize and approve ... dated February 8, 2013, among Decade Sunshine Limited, ...
(Date:5/23/2013)... Corporation (NYSE: HAE ) announced today that ... present at The Deutsche Bank 38 th Annual dbAccess ... on May 29, 2013 at 1:30pm Eastern time.  ... may access Mr. Lindop,s presentation live via webcast at: ... (NYSE: HAE ) is a global healthcare company ...
(Date:5/23/2013)... , May 23, 2013  TeamHealth Medical ... nurse triage and nurse advice lines, announces its ... comprising physician, nursing and administrative leaders, provides clinical ... quality and cost-effective services for hospital clients, physician ... national healthcare system evolves, it,s imperative to continuously ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3TeamHealth Medical Call Center Forms Clinical Advisory Committee 2
... 27, 2011 Ameritox (SM), the nation,s leader in ... Statement for the Record for the Congressional hearing on ... D Program," pointing to medication monitoring as a potential ... diversion and aiding in lowering national healthcare costs. The ...
... China, Oct. 27, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings ... a leading domestic developer, manufacturer and marketer of orthopedic ... to release third quarter 2011 financial results on November ... will hold a corresponding conference call and live webcast ...
Cached Medicine Technology:Ameritox Supports Federal Implementation of Medication Monitoring for Chronic Pain Patients 2Ameritox Supports Federal Implementation of Medication Monitoring for Chronic Pain Patients 3China Kanghui Holdings to Report Third Quarter 2011 Financial Results 2
(Date:5/25/2013)... According to an article in the June ... nearly 30 million Americans tan indoors each year and an ... knowing the health risks. New research suggests that UV ... on the brains of some tanners (Go to goo.gl/hdwnz). ... I can’t say that I fully support this contention from ...
(Date:5/25/2013)... Dr. Leslie Gerstman announced today ... lift skin on the neck, on the brow and under ... Aesthetics. , Ultherapy is a non-surgical procedure for the face ... to lift the skin over time. The use of FDA-cleared ... and then treat the deepest support layers of the skin ...
(Date:5/25/2013)... 2013 A disorder of the nerves, ... neuropathy. According to neuropathy expert doctor Helen C Lin, ... that the disorder affects almost 50% of all Diabetic ... Diabetes. The high blood sugar levels in the body ... from it usually tend to have abnormally high blood ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 – ... Materials, Packaging, & Geography: Trends & Forecasts” defines ... analysis and forecasting of the global revenue for ... restraining factors for the global food encapsulation markets ... market is segmented and revenue are forecasted on ...
(Date:5/25/2013)... 25, 2013 Absolute Surgical Specialists, serving Sun ... the NALA’s businesses throughout the country participating in Shop Local ... in the nationwide event as he understands what military families ... the Army. He said, “I wanted to give something back, ... but I live here too.” , Shop Local for a ...
Breaking Medicine News(10 mins):Health News:Sun Damage – Are UV Rays Addictive? 2Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2
... ... HIV STOPS WITH US",is the message of ... across,the country including: Boston, Long Beach and Alameda ... positive people, and a,wide spectrum of HIV negative ... providers and partners talking about real issues., ...
... using widely available and inexpensive ultrasound imaging could help ... or other adverse cardiovascular events, according to a study ... Radiology . , Researchers performed ultrasound imaging on the ... at high risk for cardiovascular disease. Of those, ultrasound ...
... reduces bleeding problems, study finds , , MONDAY, Aug. 18 (HealthDay ... wrist rather than the groin reduces the incidence of bleeding ... using the radial artery in the wrist, is not widely ... almost 600,000 catheterizations in a national database, said a report ...
... Arizona hospitals can access the new AzHHA pharmacy benefit ... immediately see improvements to their bottom ... created and is,supported by the leading pharmacy benefit consulting ... rebate,reimbursements, implementation credits and many other options not typically,available ...
... 18 Today a representative of the,Executive Board ... Local,6434 ("ULTCW") filed a letter of complaint with ... the letter written to President Stern and the ... Vice President of ULTCW and,member of its Executive ...
... Aug. 18 Actavis Group, the,international generic ... approval from the U.S. Food & Drug ... 300mg. Distribution,of the product will commence immediately., ... in,300mg strength, are the generic equivalent of ...
Cached Medicine News:Health News:New HIV Prevention/Anti-Stigma Campaign Featuring HIV Positive & Negative Persons 'TOGETHER' Launches Across the Nation 2Health News:Ultrasound used to predict heart attack risk 2Health News:Reaching the Heart Through the Wrist 2Health News:Reaching the Heart Through the Wrist 3Health News:Arizona Hospital and Healthcare Association Teams Up with ARMSRx to Bring Cost Savings to Hospitals 2Health News:Actavis Receives Approval of Generic Wellbutrin XL(R) 300mg in the U.S. 2
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe....
Siliconized PVC drains...
Bard® Channel Drain...
Used for placement of cholangiography catheters and other instruments. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: